Sunresin is proud to announce that Dr. Ivy Gao, CEO of Sunresin, has been nominated for the “Woman of the Year” category at the 2025 CPhI Awards, one of the most prestigious recognition in the pharmaceutical and life sciences industries.

The CPhI Awards Gala will take place on October 28, 2025, during the CPhI Worldwide exhibition in Frankfurt. These awards celebrate outstanding achievements in leadership, innovation, and contributions to the global pharmaceutical ecosystem.

This nomination reflects Ms. Gao’s visionary leadership, entrepreneurial spirit, and pivotal role in building Sunresin from the ground up, transforming a bold idea into a thriving international company recognized for its resin technology innovations.

Through her determination and strategic vision, Ms. Gao has led Sunresin’s evolution from a small startup to a global player with a strong presence in the life sciences and pharmaceutical industries.

“This nomination is a meaningful milestone, not only for me personally but for the entire Sunresin team,” said Ivy Gao, Sunresin's CEO. "We are working on several exciting launches and strategic initiatives aimed at revolutionizing the life sciences industry. Our goal is to continue driving innovation in resin technologies for life sciences and deliver real impact for our partners and the global biopharma community.”

The Sunresin team will attend the CPhI Awards Gala to celebrate this important moment and show their support for Ivy’s nomination.